Procurement lifecycle · 8 notices

NHS Branded Medicines Tranche A - NOFE and Midlands & East and Natalizumab for London & SOFE - 1 September 2026

Name: NHS Branded Medicines Tranche A - NOFE and Midlands & East and Natalizumab for London & SOFE - 1 September 2026
Creator: NHS England

NHS England · UKI45

Value

£665,389,588 (awarded)

First notice

22 May 2025

Latest notice

21 Jul 2026

OCID

ocds-h6vhtk-051c98

Lifecycle

1

Pipeline

2

Preliminary market engagement

3

Planned procurement

4

Tender

17 Mar 2026

5

Transparency

6

Contract award

7

Contract details

23 Jun 2026

9

Contract performance

10

Contract change

11

Contract termination

12

Procurement termination

Coloured steps have been published. Click any step to jump to that notice.

All 8 notices for this procurement, oldest first.